Charles Schwab’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.9M | Buy |
|
|||||
|
2025
Q2 | $18.7M | Buy |
|
|||||
|
2025
Q1 | $10.4M | Sell |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $17.4M | Sell |
|
|||||
|
2024
Q2 | $11.2M | Buy |
|
|||||
|
2024
Q1 | $14.2M | Buy |
|
|||||
|
2023
Q4 | $7.81M | Buy |
|
|||||
|
2023
Q3 | $4.19M | Buy |
|
|||||
|
2023
Q2 | $6.92M | Buy |
|
|||||
|
2023
Q1 | $8.84M | Buy |
|
|||||
|
2022
Q4 | $7.44M | Buy |
|
|||||
|
2022
Q3 | $6.07M | Buy |
|
|||||
|
2022
Q2 | $5.05M | Buy |
|
|||||
|
2022
Q1 | $10.8M | Buy |
|
|||||
|
2021
Q4 | $15.8M | Buy |
|
|||||
|
2021
Q3 | $14.3M | Buy |
|
|||||
|
2021
Q2 | $5.05M | Buy |
|
|||||
|
2021
Q1 | $2.43M | Buy |
|
|||||
|
2020
Q4 | $3.8M | Buy |
|